Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 11, 2019
Chinese Medicine in Cancer Treatment - How is it Practised in the East and the West?T-H So, S-K Chan, V H-F Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor betaX L Fu, H Huang, G Bentel, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injuryF M Kong, M S Anscher, T A Sporn, et al.
Annals of Surgery|August 1, 1995
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinomaS R Sue, R S Chari, F M Kong, et al.
The American Journal of Physiology|July 17, 1999
Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblastsE A van Tol, L Holt, F L Li, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trialX L Fu, G L Jiang, L J Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigenR S DiPaola, R E Weiss, K B Cummings, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
Physical and biological predictors of changes in whole-lung function following thoracic irradiationL B Marks, M T Munley, G C Bentel, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2021
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failureT C Lam, K C Tsang, H C Choi, et al.
Pageof 2